(Total Views: 188)
Posted On: 10/03/2017 3:56:08 PM
Post# of 72446
No doubt the patient doesn't know because the site investigator doesn't know also, but the investigator could've told her that she's in a trial for P. I understand why she believes she received P and not placebo since every treatment has failed for 20 years.
I don't think Nerby made up the story. I'm pretty sure he knows one anecdotal evidence isn't going to affect the stock. Besides, we already know P has the ability to clear the skin completely. In the 200 mg arm in Phase 2a, 10.7% in the ITT population and 15% in the PP population achieved clear skin (IGA 0).
If the anecdotal evidence is on an ovarian cancer patient whose tumor disappears after receiving K, that would be exciting.
I don't think Nerby made up the story. I'm pretty sure he knows one anecdotal evidence isn't going to affect the stock. Besides, we already know P has the ability to clear the skin completely. In the 200 mg arm in Phase 2a, 10.7% in the ITT population and 15% in the PP population achieved clear skin (IGA 0).
If the anecdotal evidence is on an ovarian cancer patient whose tumor disappears after receiving K, that would be exciting.
Quote:
Leo confirms that there is absolutely no way that a patient would know whether they got placebo or the drug.
(0)
(0)
